Finance

Lists
Why is NAGE up 4.10%?
Dive Deeper
NAGE:NASDAQ
Niagen Bioscience Inc
$ 2.79
+4.10%
(+0.11) 1D
$ 2.79
0.00% (0.00)
After hours
Closed: 10-р сарын 2, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
$ 2.72
High
$ 2.80
Low
$ 2.61
Mkt. cap
222.51 сая
Avg. vol.
421.25 мян
Volume
1.57 сая
52-wk high
$ 7.95
52-wk low
$ 2.61
Beta
2.02
Shares outstanding
79.13 сая
No. of employees
117
Open
$ 2.72
High
$ 2.80
Low
$ 2.61
Mkt. cap
222.51 сая
Avg. vol.
421.25 мян
Volume
1.57 сая
52-wk high
$ 7.95
52-wk low
$ 2.61
Beta
2.02
Shares outstanding
79.13 сая
No. of employees
117
News stories
From web sources and news partners
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersЛос-Анжелес, Калифорни, Америкийн Нэгдсэн Улс
SectorPersonal care products
Analyst ratings
Based on 5 analysts giving stock ratings to NAGE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NAGE in the last 3 months.
Highest
Current $ 2.79
$ 11.00 (+294.27%)
Average
$ 10.20 (+265.59%)
Lowest
$ 9.00 (+222.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Buy
Reiterated
$ 10.00
+258.4%
09/25/2026
Sean McGowan
Roth MKM
Buy
Maintained
$ 10.00
+258.4%
08/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 11.00
+294.3%
08/05/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
$ 11.00
+294.3%
07/21/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$ 9.00
+222.6%
07/06/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
$ 12.00
+330.1%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
33.99 сая
33.84 сая
31.47 сая
29.78 сая
Cost of goods sold
12.06 сая
12.14 сая
11.50 сая
10.47 сая
Cost of revenue
12.06 сая
12.14 сая
11.50 сая
10.47 сая
Research and development expenses
1.80 сая
1.71 сая
1.48 сая
1.51 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.90 сая
17.89 сая
16.92 сая
17.10 сая
Operating expense
17.69 сая
19.60 сая
18.40 сая
18.61 сая
Total operating expenses
29.75 сая
31.74 сая
29.90 сая
29.08 сая
Operating income
4.24 сая
2.10 сая
1.58 сая
700.00 мян
Other non operating income
-
-214.00 мян
-
-
EBT including unusual items
4.80 сая
4.42 сая
6.74 сая
1.07 сая
EBT excluding unusual items
4.80 сая
2.44 сая
1.95 сая
1.07 сая
Income tax expense
222.00 мян
292.00 мян
417.00 мян
106.00 мян
Effective tax rate
4.62%
6.60%
6.19%
9.92%
Other operating expenses
-
-
-
-
Net income
4.58 сая
4.13 сая
6.32 сая
963.00 мян
Net profit margin
13.47%
12.21%
20.07%
3.23%
Earnings per share
0.05
0.03
0.02
0.01
Interest and investment income
564.00 мян
552.00 мян
375.00 мян
372.00 мян
Interest expense
-
-
-
-
Net interest expenses
564.00 мян
552.00 мян
375.00 мян
372.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
4.43 сая
2.30 сая
1.87 сая
991.00 мян
Gain or loss from assets sale
-
-
-4.78 сая
26.00 мян
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс